NCT06458101

Brief Summary

A prospective, multicenter, randomized, controlled clinical trial was conducted to compare the efficacy and safety of non-indwelling catheter and indwelling catheter in relieving postoperative catheter-related complications after ureteroscopic lithotripsy. By comparing the pain score and urination urgency score (PPIUS) of patients after ureteroscopic lithotripsy (including flexible ureteroscopy) lithotripsy to provide a reliable scientific basis for indwelling catheter after ureteroscopic lithotripsy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 3, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 13, 2024

Completed
18 days until next milestone

Study Start

First participant enrolled

July 1, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

November 19, 2025

Status Verified

November 1, 2025

Enrollment Period

12 months

First QC Date

June 3, 2024

Last Update Submit

November 17, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Pain score

    pain scoring will be measured by VAS scale. There are 10 scales, with "0" and "10" at both ends. 0 indicates no pain and 10 represents the most severe pain that is unbearable.

    4 hours after surgery and 2 hours after catheter removal (same time points for non-indwelling catheters)

  • Urinary urgency score

    urinary urgency score will be measured by PPIUS scale. 0 No urgency 1. Mild urgency 2. Moderate urgency 3. Severe urgency 4. Urge incontinence

    4 hours after surgery and 2 hours after catheter removal (same time points for non-indwelling catheters)

Secondary Outcomes (3)

  • Painful Memory

    1 month after surgery

  • Operation time

    The end of operation

  • blood routine

    Before surgery and 4 hours after surgery

Study Arms (2)

Group 1: Ureteroscopy (including flexible endoscope) lithotripsy with indwelling urinary catheter

ACTIVE COMPARATOR

Ureteroscopy (including flexible endoscope) lithotripsy with indwelling urinary catheter

Procedure: Ureteroscopy (including flexible endoscope) lithotripsy with indwelling urinary catheter

Group 2: Ureteroscopy (including flexible endoscope) lithotripsy without indwelling urinary catheter

EXPERIMENTAL

Ureteroscopy (including flexible endoscope) lithotripsy without indwelling urinary catheter

Procedure: Ureteroscopy (including flexible endoscope) lithotripsy without indwelling urinary catheter

Interventions

Ureteroscopy (including flexible endoscope) lithotripsy without indwelling urinary catheter

Group 2: Ureteroscopy (including flexible endoscope) lithotripsy without indwelling urinary catheter

Ureteroscopy (including flexible endoscope) lithotripsy with indwelling urinary catheter

Group 1: Ureteroscopy (including flexible endoscope) lithotripsy with indwelling urinary catheter

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with upper urinary tract calculi undergoing rigid ureteroscopic and soft ureteroscopic lithotripsy;
  • Normal renal function;
  • Aged between 18 and 70 years old
  • Complete the operation under general anesthesia

You may not qualify if:

  • Solitary kidney;
  • Previous history of renal transplantation or urinary diversion;
  • Congenital malformation of urinary system;
  • Abnormal coagulation mechanism due to blood system diseases, liver diseases, etc.
  • Severe heart or lung disease, Malignant tumor and immunodeficiency state
  • Urethral stricture
  • Neurogenic bladder
  • Operation under epidural anesthesia or spinal anesthesia
  • Large amount of bleeding during operation should be observed by indwelling catheter to observe urine color
  • High risk factors such as large amount of pus fur should be observed during operation.
  • Urethral injury during operation leads to false passage
  • Operation time is more than 90 minutes. Higher risk of bleeding or infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai General Hospital

Shanghai, Shanghai Municipality, 200080, China

Location

MeSH Terms

Conditions

Urolithiasis

Interventions

UreteroscopyLithotripsy

Condition Hierarchy (Ancestors)

Urologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

EndoscopyDiagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisDiagnostic Techniques, UrologicalMinimally Invasive Surgical ProceduresSurgical Procedures, OperativeUrologic Surgical ProceduresUrogenital Surgical ProceduresTherapeuticsUltrasonic Surgical Procedures

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

June 3, 2024

First Posted

June 13, 2024

Study Start

July 1, 2024

Primary Completion

June 30, 2025

Study Completion

June 30, 2025

Last Updated

November 19, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will share

After the trial is completed, it is shared on the network platform: China Clinical trial Registration Center; website: http://www.chictr.org.cn

Shared Documents
STUDY PROTOCOL, ICF, CSR
Time Frame
After the trial is completed,
More information

Locations